MedPath

Convergence Dialogue Meeting With or Without Neck-specific Exercise Promoting Work Ability

Not Applicable
Withdrawn
Conditions
Workplace
Interventions
Other: convergence dialogue meeting
Registration Number
NCT04928989
Lead Sponsor
Linkoeping University
Brief Summary

The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to convergenge dialogue meeting with or without neck-specific exercise. The main outcome measure is work ability, measured via the Work Ability Score.

Detailed Description

Background: Collaboration between employees, manager and occupational health expert is needed to promote work ability. One effective method is a convergence dialogue meeting (CDM). Based on the existing work situation, factors are identified in these meetings that can strengthen the employee's work ability and opportunities for a sustainable working life. A combination of workplace and individual interventions is recommended for best effect. Neck-specific exercise (NSE) is the method with the most evidence for neck problems. NSE in evidence based form has not been investigated for work-related neck pain. More knowledge is needed regarding how CDM can be combined with NSE because clear guidelines are lacking on the best intervention for increased work ability in the case of neck problems. Also lacking are evaluations of digitally distributed CDMs and NSE with support from a web-based program for the current population. The aim of the proposed randomized controlled study is to investigate the contribution of NSE with four visits to a physiotherapist and support from a web-program in addition to three digital CDMs promoting the work situation.

Methods: The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to CDM with or without NSE. The main outcome measure is work ability, measured via the Work Ability Score. Secondary outcome measures are pain, function, health-related quality of life, work absenteeism and presenteeism, work-related factors, and cost-effectiveness. Pathophysiological aspects regarding inflammation and stress markers measured in blood and saliva will be studied, as will muscular changes measured by microdialysis. Interviews are planned with both employees and managers.

Discussion: The goal of the study is to contribute to improved rehabilitation, strengthened work ability, and a sustainable working life for employees with neck problems.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Self-reported neck problems that the person experiences as troublesome, affecting ability to perform work, and lasting at least 4 weeks.
  • Neck problems as being predominant.
  • Current neck pain ≥ 3 on the numeric rating scale (0-10) [53, 55].
  • Persons of working age, 18-65 years, who have a permanent job.
  • Neck problems clinically verified through a clinical examination to ensure study criteria are met.
  • Answers the baseline questionnaire and attends the first intervention visit.
  • Confirms being motivated to participate and completes and signs informed consent, including approval, to contact their immediate supervisor regarding a CDM.
Exclusion Criteria
  • Red flags and illness/injury that are contraindicated for or hinder exercise or may be confounding factors for the results, such as severe cardiovascular/lung disease, malignancy, severe rheumatic disease, severe neurological disease, spinal cord injury, diagnosed severe mental illness, drug or alcohol abuse, neck surgery, neck fracture or dislocation, severe cervical radiculopathy, myelopathy, general body pain (e.g., fibromyalgia, Ehlers-Danlos syndrome, generalized osteoarthritis).
  • Known pregnancy.
  • Cannot understand/communicate in Swedish and thus would be unable to understand information in the study.

For blood samples (not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added: increased tendency to bleed and use of blood thinners.

For the subgroup for microdialysis (n = 30, consecutively asked, 15 persons/group; not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added:

  • Patients who cannot imagine refraining from non-steroid anti-inflammatory drugsduring 2 days before microdialysis may not participate in the microdialysis part of the study.
  • Hypersensitivity to anesthetic and antibiotics.
  • Increased tendency to bleed and use of blood-thinning drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Convergence dialogue meetingconvergence dialogue meetingDigital counceling with convergence dialogue tripartite meeting. will be conducted in accordance with work dialogue for return to work. Workplace dialogue among employee with neck problems, an expert in the work environment, and the immediate manager. The purpose of the conversations is, in open dialogue, to reach a common understanding of the situation and identify possible interventions to maintain or improve the employee´s work ability.
Neck-specific exercise in addition to convergence dialogue meetingconvergence dialogue meetingNeck-specific exercise with digital web-based support and four visits to a physiotherapist. Neck-specific exercise will be performed based on a well-structured framework of neck-specific exercise for facilitation of deep neck muscles, increased muscle coordination, improved neck posture and increased neck muscle endurance. Plus additional convergence dialogue meeting as treatment arm no 1.
Primary Outcome Measures
NameTimeMethod
Work Ability ScoreChange in work Ability Score from baseline, to every month until the 15 month follow-up

Current work ability compared to when it was at its best

Secondary Outcome Measures
NameTimeMethod
Neck specific functionchange from baseline to 3 month and 15 month follow-up

Neck Disability Index

Time sittingchange from baseline to 3 month and 15 month

Time sitting at work and during leisure time

Intensity of pain and bothersomenesschange from baseline to 3 month and 15 month follow-up

neck pain intensity and bothersomeness, headache intensity on a numeric ratin scale.

Health related quality of lifechange from baseline to 3 month and 15 month follow-up

EQ-5D-3L

self rated functionchange from baseline to 3 month follow-up

Patient Specific Functional Scale

Work abilitychange from baseline to 3 month and 15 month follow-up

work ability index

Presenteeismchange from baseline to 3 month and 15 month follow-up

presenteeism number of days/ month and Stanford presenteeism scale

Demand-control, supportchange from baseline to 3 month and 15 month follow-up

Swedish Demand Control Support Questionnaire which is a short version of the Job centent questionnaire

Frequency of pain, symtoms and medicationschange from baseline to 3 month and 15 month follow-up

Frequency of pain, pain medication, neck stiffness, numbness/tingling into the arms, having problems lifting the arms, dizziness, sleep, concentration

Symptom satisfactionchange from baseline to 3 month and 15 month follow-up

Symptom satisfaction according to Cherkin

self-rated work situation regarding working hoursdescription and change from baseline to 3 month and 15 month follow-up

working hours

perceived exertion at workchange from baseline to 3 month and 15 month follow-up

Borg ratings of perceived exertion

Risk identifaction at workchange from baseline to 3 month and 15 month follow-up

Structured multidisciplinary work evaluation tool

Fulfilment of treatment expectation3 month and 15 month related to the patient own expectations

Fulfilment of treatment expectation, have your expectations been fulfilled: yes, yes partly, no

Adverse events/ side-effects3 month, 15 month

adverese events/ side effects of treatment in the study

Cost-effectivenessFrom the time period between baseline to 15 month follow-up

Cost effectiveness through calculation of direct costs; quantity and type of care (inside and outside the study also including drugs related to pain) from registers and from questionnaires, indirect costs;mainly production loss from registers and from questionnaire.

Interview with managers3 month, approximately n=20

Interviews with managers regarding the experience of the convergence dialogue meeting

self-rated work situation regarding satisfaction at workdescription and change from baseline to 3 month and 15 month follow-up

workplace and work satisfaction

Fear avoidancechange from baseline to 3 month and 15 month follow-up

Fear avoidance beliefs questionnaire

work situationdescription and change from baseline to 3 month and 15 month follow-up

description of work tasks

work adaptationchange from baseline to 3 month and 15 month follow-up

work adaptation such as self strategies to be able to work

Anxiety and depressionchange from baseline to 3 month and 15 month follow-up

Hospital Anxiety and Depression scale

self-rated work situation regarding self-rated work performancedescription and change from baseline to 3 month and 15 month follow-up

work performance

self-rated work situation regarding neck position at workdescription and change from baseline to 3 month and 15 month follow-up

neck position

Sick leave,change from baseline to 3 month and 15 month follow-up

sick leave numbers of days/ month

Effort-Reward Imbalancechange from baseline to 3 month and 15 month follow-up

Effort Reward Imbalance questionnaire

Satisfaction with the caregiver visits in the study3 month, 15 month

Patient enablement questionnaire

Microdialysis, tissue changes in the middle Trapeziusbaseline, 3 month, subgroup of the RCT population approximately n=30

Biomechanical changes interstitialli in M. Trapezius. Through microdialysis technology, it is possible to monitor biochemical changes interstitially in the tissue. The technique involves the exchange of substances via diffusion between the tissue and a diaphragmatic catheter inserted into the tissue and flushed by a fluid (perfusate) that is similar in chemical composition to the fluid in the muscle interstitium.

Health related quality of life on vertical visual analogue scalechange from baseline to 3 month and 15 month follow-up

EQ thermometer

self-rated work situation regarding work environmentdescription and change from baseline to 3 month and 15 month follow-up

work environment

Overall outcomechange from baseline to follw-ups at 3 month and 15 month

Global rating of change scale

Interview study of employers3 month, subgroup of the RCT population, n=20 approximately

employers experience with interventions and their impact on work ability, health and work situation

Saliva samples and blood sampleschange from baseline to 3 month in a subgroup of the RCT population, all those who agree and are without contra indication

Inflammation markers, stress markers. The samples will be taken in the morning on an empty stomach. Saliva will be collected with Salivette. Venous blood samples (10-20 ml) from the elbow fold will be collected in EDTA tubes. identification and quantification of proteins.

Observation studyDuring the 3 month treatment period at tripartiate convergence dialogue meeting

Observation study regarding the interaction between the participants in the converge dialogue meeting. Qualitative data in natural clinical settings of CDMs will be collected through video recordings (≈ 20) to find the meaning of what happen and the interactions during the dialogue. Tripartiate dialogue between patient, manager and care giver regarding the work situation and how to improve it.

self-rated work situation regarding stress at workdescription and change from baseline to 3 month and 15 month follow-up

work stress

Exercise/physical activity levelchange from baseline to 3 month and 15 month follow-up

Exercise/physical activity level

Trial Locations

Locations (2)

Anneli Peolsson

🇸🇪

Linkoping, Ostergotland, Sweden

Dep. Medical and Health Sciences, Physiotherapy

🇸🇪

Linköping, Östergötland, Sweden

© Copyright 2025. All Rights Reserved by MedPath